Researchers report a group of genes previously associated with rare forms of epilepsy may also contribute to common forms of the disorder. Read More
A low dose of the sedative clonazepam alleviated autistic-like behavior in mice with a mutation that causes Dravet syndrome in humans. Read More
A cannabis derivative reduced seizure frequency by 39% in patients with Dravet syndrome. Read More
Using purified botanical cannabidiol (CBD) to treat mouse models of Davet syndrome improved mortality and reduced behavioral symptoms associated with the condition. Read More
Mice expressing a specific variant of the Scn1a gene associated with Dravet syndrome exhibited spontaneous seizures, disordered breathing and died prematurely. Read More
Researchers report cannabidiol could help treat children with severe epilepsy who have not responded to other therapies. Read More
By turning skin cells of patients with Dravet syndrome into neurons, researchers create a miniature testing ground for epilepsy Read More
Researchers have identified a network of 320 genes they believe to be associated with epilepsy. Read More
A new study reports that reducing levels of tau protein in the brain effectively blocks the development of Dravet syndrome in mouse models. Read More
A new study reviews the use of medical marijuana as a potential treatment for childhood seizures. Read More
Huperzine A, a compound that comes from a club moss, has been shown to increase resistance to induced seizures in mouse models of genetic epilepsy, a new study reports. Read More
Researchers say a new cannabis derived drug, which is expected to receive full approval from the FDA this week, will be a vital intervention for children with Dravet Syndrome and Lennox-Gastaut syndrome. Read More
